✦ LIBER ✦

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

✍ Scribed by Negoro, S; Masuda, N; Takada, Y; Sugiura, T; Kudoh, S; Katakami, N; Ariyoshi, Y; Ohashi, Y; Niitani, H; Fukuoka, M

Book ID: 109997463
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 133 KB
Volume: 88
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600725

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of irinotecan and infusi

A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer

✍ K. Mori; Tsukasa Ohnishi; Kohki Yokoyama; Keigo Tominaga 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 128 KB

Phase II trial of irinotecan, cisplatin

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer

✍ Dean A. Fennell; Jeremy P.C. Steele; Jonathan Shamash; Sarah E. Slater; Michael 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB 👁 1 views

## Abstract There is no standard therapy for relapsed small cell lung cancer (rSCLC). We evaluated the efficacy and toxicity of a new triplet consisting of irinotecan (100 mg/m^2^ Days 1 and 15 q28), cisplatin (40 mg/m^2^ Days 1 and 15 q28) and mitomycin (6 mg/m^2^ d1 q28) administered to a maximum

Dose escalation study of irinotecan comb

Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer

✍ Koji Takeda; Shunichi Negoro; Nobuhide Takifuji; Takashi Nitta; Naruo Yoshimura; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Phase II trial of gemcitabine plus cispl

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

✍ Yu, Hai-feng; Wu, Feng-qin; Fan, Yun; Lin, Neng-ming; Ma, Sheng-lin; Luo, Lü-hon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 Chinese ⚖ 317 KB

Randomised phase II trial of irinotecan

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

✍ Sekine, I; Nokihara, H; Takeda, K; Nishiwaki, Y; Nakagawa, K; Isobe, H; Mori, K; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB